In addition, the patients with malignant tumors were significantly older than the healthy controls and the patients with benign tumors, and no differences were observed between the cohorts with malignant and benign tumors with regard to their baseline serum CRP levels, WBC counts, and reference values. This evidence concerns the gene CRP and benign neoplasm.